Regulatory demands on data quality for the environmental risk assessment of pharmaceuticals

被引：31
|
作者：
Kuester, A. [1 ]
Bachmann, J. [1 ]
Brandt, U. [1 ]
Ebert, I. [1 ]
Hickmann, S. [1 ]
Klein-Goedicke, J. [1 ]
Maack, G. [1 ]
Schmitz, S. [1 ]
Thumm, E. [1 ]
Rechenberg, B. [1 ]
机构：
[1] Fed Environm Agcy, Pharmaceut Washing & Cleansing Agents, D-06813 Dessau, Germany
来源：
REGULATORY TOXICOLOGY AND PHARMACOLOGY | 2009年 / 55卷 / 03期
关键词：
Pharmaceuticals; Environmental risk assessment; Regulatory authorities; Quality criteria;
D O I：
10.1016/j.yrtph.2009.07.005
中图分类号：
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号：
0301 ; 10 ;
摘要：
The evaluation of the quality of data and their use within the review of environmental risk assessment of human as well as veterinary pharmaceuticals is described from a regulatory point of view. A definition and differentiation in three categories for the reliability of data are given. Existing criteria relating to international testing standards for categorising reliability are adopted for their use within the environmental risk assessment of pharmaceuticals. A systematic documentation of evaluating reliability for literature data as well as for experimental studies (effect and environmental fate studies) is proposed. The data quality criteria are defined in order to increase the transparency of the evaluation process in Germany and thus the quality of the environmental risk assessment of pharmaceuticals. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码：276 / 280
页数：5
相关论文
共 50 条
  • [1] Challenges of Regulatory Environmental Risk Assessment for Human Pharmaceuticals with Focus on Antibiotics
    Wess, R. Arno
    Schmidt, Thomas
    Hoeger, Stefan
    CHIMIA, 2020, 74 (03) : 183 - 191
  • [2] Environmental risk assessment of pharmaceuticals
    Bogers, Rinus
    Bouwman, Lydia
    CHIMICA OGGI-CHEMISTRY TODAY, 2006, 24 (05) : 44 - 45
  • [3] Environmental risk assessment of pharmaceuticals
    Conto, A
    Meriano, E
    CHIMICA OGGI-CHEMISTRY TODAY, 2005, 23 (05) : 62 - 64
  • [4] Environmental Assessment of Pharmaceuticals in Canada: A Regulatory Perspective
    Andrew Beck
    Drug information journal : DIJ / Drug Information Association, 2007, 41 : 159 - 162
  • [5] Environmental assessment of pharmaceuticals in Canada: A regulatory perspective
    Beck, Andrew
    DRUG INFORMATION JOURNAL, 2007, 41 (02): : 159 - 162
  • [6] The environmental risk assessment of human pharmaceuticals in the overall EU regulatory affairs process
    Laenge, Reinhard
    Steger-Hartmann, Thomas
    Schweinfurth, Hermann
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2006, 45 (03) : 223 - 228
  • [7] Exploiting monitoring data in environmental exposure modelling and risk assessment of pharmaceuticals
    Boxall, A. B. A.
    Keller, V. D. J.
    Straub, J. O.
    Monteiro, S. C.
    Fussell, R.
    Williams, R. J.
    ENVIRONMENT INTERNATIONAL, 2014, 73 : 176 - 185
  • [8] USE OF ACUTE AND CHRONIC ECOTOXICITY DATA IN ENVIRONMENTAL RISK ASSESSMENT OF PHARMACEUTICALS
    Vestel, Jessica
    Caldwell, Daniel J.
    Constantine, Lisa
    D'Aco, Vincent J.
    Davidson, Todd
    Dolan, David G.
    Millard, Steven P.
    Murray-Smith, Richard
    Parke, Neil J.
    Ryan, Jim J.
    Straub, Juerg Oliver
    Wilson, Peter
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2016, 35 (05) : 1201 - 1212
  • [9] Exploiting monitoring data in environmental exposure modeling and risk assessment of pharmaceuticals
    Boxall, Alistair B. A.
    Williams, Richard
    Keller, Virginie
    Straub, Jurg Oliver
    Monteiro, Sara
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [10] Improving the regulatory environmental risk assessment of human pharmaceuticals: Required changes in the new legislation
    Gildemeister, Daniela
    Moermond, Caroline T. A.
    Berg, Cecilia
    Bergstrom, Ulrika
    Bielska, Lucie
    Evandri, Maria Grazia
    Franceschin, Marco
    Kolar, Boris
    Montforts, Mark H. M. M.
    Vaculik, Christine
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2023, 142
12345